<DOC>
	<DOCNO>NCT01347528</DOCNO>
	<brief_summary>TELEMED-HF randomize , control clinical intervention trial design : ( 1 ) examine efficacy electronic Medication Adherence Support System ( MASS ) improve monitor patient ' medication adherence ; ( 2 ) determine effect medication adherence hospitalization health care consumption .</brief_summary>
	<brief_title>Improving MEDication Adherence Chronic Heart Failure Using TELEmedicine Device ( TELEMED-HF )</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Stable systolic heart failure New York Heart Association functional class IIIII , decrease pump function ( left ventricular ejection fraction ( LVEF ) &lt; 45 % ) Titrated optimal dos ACEinhibitor Angiotensin Receptor Blocker , betablocker Receiving stable dos least 3 heart failure medication ( multiple time day ) 1 month plan add adjust heart failure medication titrate immediate future . Age young 50 year Diastolic heart failure ( intact pump function ) Myocardial infarction , invasive treatment ( percutaneous coronary intervention ( PCI ) coronary artery bypass grafting ( CABG ) ) , hospitalization within 1 month prior inclusion Lifethreatening comorbid condition ( e.g. , cancer ) Diminished mental capacity ( suspect cognitive decline confirm mini mental state examination ( MMSE ) ) History psychiatric disorder apart affective disorder ( depression anxiety disorder )</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Medication adherence</keyword>
	<keyword>Heart failure</keyword>
	<keyword>Telemonitoring</keyword>
	<keyword>Determinants adherence</keyword>
</DOC>